Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
2001 1
2002 1
2003 1
2004 1
2006 2
2007 3
2008 2
2010 2
2011 2
2013 1
2015 2
2016 2
2017 1
2018 3
2019 4
2020 4
2021 5
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse.
Dimopoulos M, Weisel K, Moreau P, Anderson LD Jr, White D, San-Miguel J, Sonneveld P, Engelhardt M, Jenner M, Corso A, Dürig J, Pavic M, Salomo M, Casal E, Srinivasan S, Yu X, Nguyen TV, Biyukov T, Peluso T, Richardson P. Dimopoulos M, et al. Among authors: salomo m. Leukemia. 2021 Jun;35(6):1722-1731. doi: 10.1038/s41375-020-01021-3. Epub 2020 Sep 7. Leukemia. 2021. PMID: 32895455 Free PMC article. Clinical Trial.
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics.
Richardson PG, Schjesvold F, Weisel K, Moreau P, Anderson LD Jr, White D, Rodriguez-Otero P, Sonneveld P, Engelhardt M, Jenner M, Corso A, Dürig J, Pavic M, Salomo M, Beksac M, Oriol A, Lindsay J, Liberati AM, Galli M, Robak P, Larocca A, Yagci M, Vural F, Kanate AS, Jiang R, Grote L, Peluso T, Dimopoulos M. Richardson PG, et al. Among authors: salomo m. Eur J Haematol. 2022 Jan;108(1):73-83. doi: 10.1111/ejh.13706. Epub 2021 Sep 22. Eur J Haematol. 2022. PMID: 34496096 Free PMC article. Clinical Trial.
How to exhaust your bone marrow.
Salomo L, Salomo M, Andersen SA, Kamper AL. Salomo L, et al. Among authors: salomo m. BMJ Case Rep. 2013 Jun 21;2013:bcr2013009210. doi: 10.1136/bcr-2013-009210. BMJ Case Rep. 2013. PMID: 23813507 Free PMC article.
Two Decades of Cardiac Amyloidosis: A Danish Nationwide Study.
Westin O, Butt JH, Gustafsson F, Schou M, Salomo M, Køber L, Maurer M, Fosbøl EL. Westin O, et al. Among authors: salomo m. JACC CardioOncol. 2021 Aug 17;3(4):522-533. doi: 10.1016/j.jaccao.2021.05.004. eCollection 2021 Oct. JACC CardioOncol. 2021. PMID: 34729524 Free PMC article.
Association of Choroidal Effusion and Infusion of Daratumumab.
Rasmussen PK, Kiilgaard JF, Salomo M. Rasmussen PK, et al. Among authors: salomo m. JAMA Ophthalmol. 2019 Jul 1;137(7):853-854. doi: 10.1001/jamaophthalmol.2019.1427. JAMA Ophthalmol. 2019. PMID: 31095248 No abstract available.
Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry.
Redder L, Klausen TW, Vangsted AJ, Gregersen H, Andersen NF, Pedersen RS, Szabo AG, Frederiksen M, Frølund UC, Helleberg C, Nielsen LK, Pedersen PT, Salomo M, Gimsing P, Frederiksen H, Abildgaard N. Redder L, et al. Among authors: salomo m. Br J Haematol. 2021 Apr;193(1):119-124. doi: 10.1111/bjh.16806. Epub 2020 Jun 9. Br J Haematol. 2021. PMID: 32515050 Free article.
A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma.
Hansson M, Gimsing P, Badros A, Niskanen TM, Nahi H, Offner F, Salomo M, Sonesson E, Mau-Sorensen M, Stenberg Y, Sundberg A, Teige I, Van Droogenbroeck J, Wichert S, Zangari M, Frendeus B, Korsgren M, Poelman M, Tricot G. Hansson M, et al. Among authors: salomo m. Clin Cancer Res. 2015 Jun 15;21(12):2730-6. doi: 10.1158/1078-0432.CCR-14-3090. Epub 2015 Feb 24. Clin Cancer Res. 2015. PMID: 25712687 Clinical Trial.
Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study.
Sørrig R, Klausen TW, Salomo M, Vangsted AJ, Østergaard B, Gregersen H, Frølund UC, Andersen NF, Helleberg C, Andersen KT, Pedersen RS, Pedersen P, Abildgaard N, Gimsing P; Danish Myeloma Study Group. Sørrig R, et al. Among authors: salomo m. Eur J Haematol. 2016 Sep;97(3):303-9. doi: 10.1111/ejh.12728. Epub 2016 Feb 5. Eur J Haematol. 2016. PMID: 26710662
33 results